Pfizer’s Buying Spree Continues With GBT, Gaining A Sickle Cell Disease Franchise

 
• By Jessica Merrill
  
Sickle Cell Disease
Pfizer is expanding in the sickle cell disease space with GBT acquisition • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Blood and Clotting

More from Therapeutic Category